Comparing Canadian TIA Score and ABCD2 Score for Stroke Risk in TIA Patients
Official title: Canadian TIA Score Versus ABCD2 Score in Risk Stratification of Transient Ischemic Attack (TIA)
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06718075 · Data updated 2026-11-12
This study is testing whether the Canadian TIA score is better than the ABCD2 score at predicting stroke risk in patients who have had a transient ischemic attack (TIA).
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | August 31, 2025 |
| Study ends | August 31, 2025 |
| Registry record updated | December 5, 2024 |
| Trial ID | NCT06718075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include all adult patients presenting to the emergency department with a diagnosis of transient ischemic attack.
✕Probably not a fit
Patients who do not present with a transient ischemic attack or those who cannot provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the effectiveness of the Canadian TIA score compared to the ABCD2 score in predicting the risk of stroke or carotid revascularization in patients who have experienced a transient ischemic attack (TIA). Conducted at the Emergency Medicine department of IRCCS AOU di Bologna, the study will enroll approximately 800 adult patients over a 24-month period. Prognostic scores will be assessed at the time of admission, and follow-up will occur at 7 and 90 days post-admission to monitor outcomes. The goal is to identify high-risk patients for optimized management and treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and management of patients following a transient ischemic attack, potentially reducing the incidence of subsequent strokes.
How similar studies have gone: While the ABCD2 score has been widely used, the Canadian TIA score is a newer approach that has not been extensively validated outside of Canada, making this study a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients presenting to the emergency department with a diagnosis of TIA * all adult patients * all patients who have signed the informed consent Exclusion Criteria: * none
Where it's running
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Veronica Salvatore, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Veronica Salvatore, MD
- Email: veronica.salvatore@aosp.bo.it
- Phone: +39 0512144716
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy
This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.
-
Same-day ambulatory stroke unit care for older adults with minor stroke or TIA
This trial will try whether same-day ambulatory stroke unit care works as well as inpatient stroke unit care for people aged 60 and older with minor ischemic stroke, transient ischemic attack, or retinal ischemia.
-
Comparing Cocoon vs Amplatzer PFO Occluders in Adults After Stroke or TIA
This trial tests whether the Cocoon PFO Occluder works as well as the Amplatzer PFO Occluder in adults who had a cryptogenic stroke or TIA and have a PFO requiring closure.
-
Intelligent lipid-management system to help stroke or TIA patients on evolocumab reach one-year LDL-C targets
We will test whether an intelligent lipid-management decision-support system helps adults in China with ischemic stroke or TIA who are taking evolocumab reach LDL-C under 1.8 mmol/L after one year.
-
Cardiovascular risk in people with Crohn's disease and ulcerative colitis
This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.
-
Genetic testing for personalized medication in stroke patients
This study is testing if using genetic testing can help doctors choose the best medication for stroke patients to improve their treatment and recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.